PMID- 34861044
OWN - NLM
STAT- MEDLINE
DCOM- 20220307
LR  - 20220307
IS  - 1897-4279 (Electronic)
IS  - 0022-9032 (Linking)
VI  - 79
IP  - 12
DP  - 2021
TI  - Mechanical circulatory support. An expert opinion of the Association of Intensive 
      Cardiac Care and the Association of Cardiovascular Interventions of the Polish 
      Cardiac Society.
PG  - 1399-1410
LID - 10.33963/KP.a2021.0169 [doi]
AB  - Mechanical circulatory support (MCS) methods are used in patients with both acute 
      and chronic heart failure, who have exhausted other options for pharmacological 
      or surgical treatments. The purpose of their use is to support, partially or 
      completely, the failed ventricles and ensure adequate organ perfusion, which 
      allows patients to restore full cardiovascular capacity, prolonging their life 
      and effectively improving its quality. The three most popular devices include an 
      intra-aortic balloon pump (IABP), percutaneous assist devices (including Impella, 
      TandemHeart), and venoarterial extracorporeal membrane oxygenation (VA-ECMO). A 
      multidisciplinary approach with the special participation of the Heart Team is 
      required to determine the proper MCS strategy, the choice of the supporting 
      method, and the time of its use. The studies published so far do not allow us to 
      determine which MCS method is the safest and the most effective. Thus, the site 
      experience and accessibility of the method seem to matter most today. MCS finds 
      particular application in patients with acute coronary syndromes complicated by 
      refractory cardiogenic shock, as well as in patients with acute heart failure of 
      the high potential for reversibility. It can also serve as a backup for 
      percutaneous coronary interventions of high risk (complex and high-risk indicated 
      percutaneous coronary intervention [PCI], complex and high-risk indicated PCI 
      [CHIP]). The use of appropriate supportive drugs, precise hemodynamic and 
      echocardiographic monitoring, as well as optimal non-invasive or mechanical 
      ventilation, are extremely important in the management of a patient with MCS. The 
      most serious complications of MCS include bleeding, thromboembolic events, as 
      well as infections, and hemolysis.
FAU - Tycinska, Agnieszka
AU  - Tycinska A
AD  - Department of Cardiology, Medical University of Bialystok, Bialystok, Poland. 
      agnieszka.tycinska@gmail.com.
FAU - Grygier, Marek
AU  - Grygier M
AD  - 1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, 
      Poland.
FAU - Biegus, Jan
AU  - Biegus J
AD  - Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
FAU - Czarnik, Tomasz
AU  - Czarnik T
AD  - Department of Anesthesiology and Intensive Care, Institute of Medical Sciences, 
      University of Opole, Opole, Poland.
FAU - Dabrowski, Maciej
AU  - Dabrowski M
AD  - Department of Interventional Cardiology and Angiology, National Institute of 
      Cardiology, Warszawa, Poland.
FAU - Depukat, Rafal
AU  - Depukat R
AD  - Department of Anesthesiology and Intensive Care, University Hospital, Krakow, 
      Poland.
FAU - Gierlotka, Marek
AU  - Gierlotka M
AD  - Department of Cardiology, Institute of Medical Sciences, University of Opole, 
      Opole, Poland.
FAU - Gil, Monika
AU  - Gil M
AD  - Department of Cardiology, Medical University of Bialystok, Bialystok, Poland.
FAU - Hawranek, Michal
AU  - Hawranek M
AD  - 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical 
      University of Silesia, Katowice, Poland.
FAU - Hirnle, Tomasz
AU  - Hirnle T
AD  - Department of Cardiac Surgery, Medical University of Bialystok, Bialystok, 
      Poland.
FAU - Jemielity, Marek
AU  - Jemielity M
AD  - Department of Cardiac Surgery and Transplantology, Poznan University of Medical 
      Sciences, Poznan, Poland.
FAU - Kapelak, Boguslaw
AU  - Kapelak B
AD  - John Paul II Hospital, Krakow, Poland.
AD  - Department of Cardiovascular Surgery and Transplantology, Institute of 
      Cardiology, Jagiellonian University Medical College, Krakow, Poland.
FAU - Kralisz, Pawel
AU  - Kralisz P
AD  - Department of Invasive Cardiology, Medical University of Bialystok, Bialystok, 
      Poland.
FAU - Kuliczkowski, Wiktor
AU  - Kuliczkowski W
AD  - Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
FAU - Kusmierczyk, Mariusz
AU  - Kusmierczyk M
AD  - National Institute of Cardiology, Warszawa, Poland.
FAU - Ligowski, Marcin
AU  - Ligowski M
AD  - Department of Cardiac Surgery and Transplantology, Poznan University of Medical 
      Sciences, Poznan, Poland.
FAU - Lopatowska, Paulina
AU  - Lopatowska P
AD  - Department of Cardiology, Medical University of Bialystok, Bialystok, Poland.
FAU - Puslecki, Mateusz
AU  - Puslecki M
AD  - Department of Cardiac Surgery and Transplantology, Poznan University of Medical 
      Sciences, Poznan, Poland.
AD  - Department of Medical Rescue, Poznan University of Medical Sciences, Poznan, 
      Poland.
FAU - Swiatkowski, Andrzej
AU  - Swiatkowski A
AD  - Intensive Cardiac Care Unit, 1st Department of Cardiology and Angiology, Silesian 
      Center of Heart Diseases, Zabrze, Poland.
FAU - Trzeciak, Przemyslaw
AU  - Trzeciak P
AD  - 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical 
      University of Silesia, Katowice, Poland.
FAU - Zawislak, Barbara
AU  - Zawislak B
AD  - Intensive Cardiac Care Unit, University Hospital, Krakow, Poland.
FAU - Zembala, Michal
AU  - Zembala M
AD  - Department of Cardiac Surgery, Heart and Lung Transplantation and Mechanical 
      Circulatory Support, Silesian Center For Heart Diseases, Zabrze, Poland.
AD  - Pomeranian Medical University, Szczecin, Poland.
FAU - Zymlinski, Robert
AU  - Zymlinski R
AD  - Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
LA  - eng
PT  - Journal Article
DEP - 20211203
PL  - Poland
TA  - Kardiol Pol
JT  - Kardiologia polska
JID - 0376352
SB  - IM
MH  - Expert Testimony
MH  - *Heart-Assist Devices/adverse effects
MH  - Humans
MH  - Intra-Aortic Balloon Pumping/adverse effects/methods
MH  - *Percutaneous Coronary Intervention/adverse effects
MH  - Poland
MH  - Shock, Cardiogenic/therapy
OTO - NOTNLM
OT  - hemodynamic and echocardiographic monitoring
OT  - indications and complications
OT  - mechanical circulatory support-type and extension
OT  - multidisciplinary approach
OT  - ventilation and pharmacotherapy
EDAT- 2021/12/04 06:00
MHDA- 2022/03/08 06:00
CRDT- 2021/12/03 17:33
PHST- 2021/12/03 00:00 [received]
PHST- 2021/12/03 00:00 [accepted]
PHST- 2021/12/04 06:00 [pubmed]
PHST- 2022/03/08 06:00 [medline]
PHST- 2021/12/03 17:33 [entrez]
AID - VM/OJS/J/87250 [pii]
AID - 10.33963/KP.a2021.0169 [doi]
PST - ppublish
SO  - Kardiol Pol. 2021;79(12):1399-1410. doi: 10.33963/KP.a2021.0169. Epub 2021 Dec 3.